Cytena Founds Subsidiary in Taiwan
Cytena is continuing its growth with the establishment of its subsidiary Cytena bioprocess Solutions in Taiwan. Cytena Bioprocess Solutions is developing an innovative technology, which enables considerable reductions in time and increases in efficiency for cell line development.
"With the new R&D focused company, we want to further strengthen our global market position and open up new application areas and target markets. Our team in Taipei will enable us to be even closer to our Asian partners and use local R&D and production resources," says Dr. Jonas Schoendube, CEO of Cytena in Germany.
Cytena Bioprocess Solutions will focus on providing bioprocess solutions for pharmaceutical companies and leading research institutes.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Cancer screening from home? - Detection with independently taken samples can work
Protein helps prevent damaged DNA in yeast
Cornell Chronicle: Leaf gene changes increase corn yield - Technique allows researchers to identify key maize genes for increased yield

Bayer invests USD 50 Million in eGenesis Series B financing round - Investment to support development of human-compatible xeno organs to address the global organ shortage crisis

Synthesis of pharmaceuticals with light
DIREVO Announces Incorporation of Industrial Biotechnology Subsidiary
